16
Mar
2011
Tools and Resources PDF Print E-mail

 

The CCS is committed to making these valuable resources and educational tools available to its members and the Canadian cardiovascular care community at-large to further disseminate the CCS Atrial Fibrillation Recommendations. Currently we offer resources and educational tools in both Microsoft PowerPoint and Adobe PDF versions, please click on the links below for to access the available resources.

 

Atrial Fibrillation Guidelines App

The CCS Atrial Fibrillation Guidelines App is a tool developed by the Canadian Cardiovascular Society (CCS) to provide a clear and concise summary of the Atrial Fibrillation guidelines published in 2011 and the 2012 update.

 

icon_afapp_store_badge_en_0609

 

>> more CCS Apps

 

Pocket Guides


Version

adobe-swf_icon

English

Online Version

French Online Version

Use our online order form to request your free copies

 


Slide Decks

 
2012 capture adobecapture
English Powerpoint PDF
French
Powerpoint PDF


Supplimentary Articles


  • Viewpoint: Comparing the 2010 North American and European Atrial Fibrillation Guidelines

  • Clinical Research: Atrial Fibrillation Care: Challenges in Clinical Practice and Educational Needs Assessment

  • Basic Research: Arrythmogenic Consequences of Action Potential Duration Gradients in the Atria

  • Case Report: Posterior His Bundle Electrogram Location in a Patient With Atrioventricular Nodal Reentrant Tachycardia and Structurally Normal Heart



CCS Atrial Fibrillation Webinars


 

Online Learning



 

It is Canadian Cardiovascular Society (CCS) policy that no industry support is accepted for the development of guidelines or position statements.

The CCS accepts third party funding for guideline knowledge translation activities, seeking multiple supporters whenever possible. Support is accepted to offset the development costs of tools and materials such as pocket guide printing, website development, app development, distribution of journal supplements, etc.. Supporters have no involvement in content development. Atrial Fibrillation Guideline knowledge translation is currently supported by: Pfizer and Boehringer Ingelheim.

pfizer

 

boehringer

Last Updated on Monday, 25 March 2013